Abstract Introduction and Aims Cognitive impairments in substance use disorder predict
treatment outcome and are assumed to differ between substances. They often go …

BACKGROUND: To compare the cognitive performances of maintenance patients (MAIN),
abstinent ex-users (ABST) and healthy non-heroin using controls (CON). METHODS: Case …

BACKGROUND: Cannabis is the most widely used illicit substance and has been
associated with cognitive impairment. It is unclear whether such impairment can occur in the …

Background and objectives: Neuropsychological impairment among patients with substance
use disorders (SUDs) contributes to poorer treatment processes and outcomes. However …

To date, there has not been a time-efficient and resource-conscious way to identify cognitive
impairment in patients with substance use disorders (SUDs). In this study, we assessed the …

Background: Cocaine use disorder is associated with cognitive deficits. However, the
literature remains somewhat ambiguous with respect to which distinct cognitive functions are …

Neuropsychological assessment of substance abusers frequently proves useful for the
evaluation of those aspects of cognitive functioning that may be relevant for optimal …

Amlodipine is a calcium-channel antagonist with neuropharmacological properties believed
to be protective against cerebral hypoperfusion, microinfarcts, and excitoxic cell death …

Background: Research has demonstrated that patients with opioid use disorders (OUD;
including both opioid abuse and/or dependence) have poorer neuropsychological …

Cannabis is the most widely used illicit substance in the world, and demand for effective
treatment is increasing. However, abstinence rates following behavioral therapies have …